L Ceremuźyński

4.1k total citations
76 papers, 1.5k citations indexed

About

L Ceremuźyński is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine. According to data from OpenAlex, L Ceremuźyński has authored 76 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cardiology and Cardiovascular Medicine, 11 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Pathology and Forensic Medicine. Recurrent topics in L Ceremuźyński's work include Cardiac electrophysiology and arrhythmias (24 papers), Cardiac Ischemia and Reperfusion (9 papers) and Cardiovascular Function and Risk Factors (8 papers). L Ceremuźyński is often cited by papers focused on Cardiac electrophysiology and arrhythmias (24 papers), Cardiac Ischemia and Reperfusion (9 papers) and Cardiovascular Function and Risk Factors (8 papers). L Ceremuźyński collaborates with scholars based in Poland, United Kingdom and Brazil. L Ceremuźyński's co-authors include K Herbaczyńska-Cedro, J Staszewska-Barczak, Andrzej Budaj, Salim Yusuf, Robert Wołk, Leopoldo Soares Piegas, Keith A.A. Fox, Marcus Flather, George Varigos and Mátyás Keltai and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

L Ceremuźyński

73 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Ceremuźyński Poland 17 1.1k 238 229 164 155 76 1.5k
D S Reid United Kingdom 17 841 0.8× 249 1.0× 191 0.8× 45 0.3× 112 0.7× 35 1.1k
Peter E. Pool United States 26 1.7k 1.5× 288 1.2× 305 1.3× 240 1.5× 483 3.1× 57 2.5k
Åke Hjalmarson Sweden 20 1.3k 1.2× 230 1.0× 144 0.6× 94 0.6× 230 1.5× 35 1.7k
Najam A. Awan United States 25 1.7k 1.6× 200 0.8× 620 2.7× 137 0.8× 155 1.0× 77 2.0k
Neil P. Andrews United States 16 837 0.8× 160 0.7× 237 1.0× 92 0.6× 126 0.8× 21 1.4k
F Burkart Switzerland 26 2.1k 1.9× 332 1.4× 463 2.0× 210 1.3× 245 1.6× 117 2.7k
John E. Strobeck United States 18 1.3k 1.2× 211 0.9× 324 1.4× 78 0.5× 309 2.0× 44 1.7k
J. N. Cohn United States 22 1.8k 1.6× 206 0.9× 491 2.1× 88 0.5× 213 1.4× 41 2.2k
Jaan Eha Estonia 22 881 0.8× 78 0.3× 299 1.3× 120 0.7× 176 1.1× 72 1.5k
Henry A. Oldewurtel United States 19 1.3k 1.2× 334 1.4× 175 0.8× 165 1.0× 395 2.5× 33 1.9k

Countries citing papers authored by L Ceremuźyński

Since Specialization
Citations

This map shows the geographic impact of L Ceremuźyński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Ceremuźyński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Ceremuźyński more than expected).

Fields of papers citing papers by L Ceremuźyński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Ceremuźyński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Ceremuźyński. The network helps show where L Ceremuźyński may publish in the future.

Co-authorship network of co-authors of L Ceremuźyński

This figure shows the co-authorship network connecting the top 25 collaborators of L Ceremuźyński. A scholar is included among the top collaborators of L Ceremuźyński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Ceremuźyński. L Ceremuźyński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herbaczyńska-Cedro, K & L Ceremuźyński. (2010). Vane blood-bathed technique reveals the significance of adrenergic reaction in myocardial infarction. Pharmacological Reports. 62(3). 457–461. 1 indexed citations
2.
Wołk, Robert, et al.. (2004). Prognostic value of exercise-induced QT dispersion in patients after acute myocardial infarction.. PubMed. 61(11). 442–50. 1 indexed citations
3.
Herbaczyńska-Cedro, K, et al.. (2004). L-arginine supplementation prolongs duration of exercise in congestive heart failure. Kardiologia Polska. 60(4). 351–353. 6 indexed citations
4.
Cybulski, Jacek, et al.. (2003). Intravenous amiodarone in cardioversion of new-onset atrial fibrillation. Journal of the American College of Cardiology. 41(6). 85–85. 2 indexed citations
5.
Wołk, Robert, et al.. (2001). Effects of Glucose‐Insulin‐Potassium Infusion on QT Dispersion in Patients with Acute Myocardial Infarction. Annals of Noninvasive Electrocardiology. 6(1). 50–54. 2 indexed citations
6.
Ceremuźyński, L, et al.. (2000). Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. Journal of Internal Medicine. 247(1). 78–86. 64 indexed citations
7.
Wołk, Robert, et al.. (2000). Effects of oral l-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris. International Journal of Cardiology. 75(2-3). 205–210. 23 indexed citations
8.
Yusuf, Salim, Marcus Flather, Janice Pogue, et al.. (1998). Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. The Lancet. 352(9127). 507–514. 272 indexed citations
9.
Herbaczyńska-Cedro, K, et al.. (1996). Effects of antioxidant vitamins C and E on signal-averaged electrocardiogram in acute myocardial infarction. The American Journal of Cardiology. 77(4). 237–241. 19 indexed citations
10.
Budaj, Andrzej, J Kuch, Maria Krzemińska‐Pakuła, et al.. (1996). Lack of effect of amiodarone on survival after extensive infarction. Coronary Artery Disease. 7(4). 315–320. 9 indexed citations
11.
12.
Ceremuźyński, L. (1993). Secondary prevention after myocardial infarction with class III antiarrhythmic drugs. The American Journal of Cardiology. 72(16). F82–F86. 7 indexed citations
13.
Ceremuźyński, L, Maria Krzemińska‐Pakuła, J Kuch, et al.. (1992). Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot study. Journal of the American College of Cardiology. 20(5). 1056–1062. 232 indexed citations
14.
Kułakowski, Piotr, et al.. (1992). The Value of Transesophageal Atrial Pacing in Predicting the Efficacy of Antiarrhythmic Drugs in Patients with Paroxysmal Narrow QRS Complex Tachycardia. Pacing and Clinical Electrophysiology. 15(6). 895–904. 5 indexed citations
15.
Ceremuźyński, L, et al.. (1991). Stress-induced injury of pig myocardium is accompanied by increased lipid peroxidation and depletion of mitochondrial ATP. Experimental Pathology. 43(3-4). 213–220. 10 indexed citations
16.
17.
Herbaczyńska-Cedro, K, et al.. (1990). Increased activity of circulating polymorphonuclear leukocytes in acute myocardial infarction. International Journal of Cardiology. 27(3). 392–393. 4 indexed citations
18.
Dłużniewski, Mirosław, et al.. (1989). Platelet aggregation and arrhythmias after myocardial infarction. International Journal of Cardiology. 23(1). 137–138. 1 indexed citations
19.
Ceremuźyński, L, E Nartowicz, Mirosław Dłużniewski, et al.. (1987). ST 567 compared with propranolol in stable angina. European Heart Journal. 8(suppl L). 159–163. 1 indexed citations
20.
Ceremuźyński, L, et al.. (1979). Effects of beta-blocking agent Metipranolol on metabolic variables in patients with ischemic heart disease, hyperkinetic syndrome, hyperthyreosis and in healthy subjects.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 17(6). 244–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D S Reid Breakdown of academic impact, for papers by Peter E. Pool Breakdown of academic impact, for papers by Åke Hjalmarson Breakdown of academic impact, for papers by Najam A. Awan Breakdown of academic impact, for papers by Neil P. Andrews Breakdown of academic impact, for papers by F Burkart Breakdown of academic impact, for papers by John E. Strobeck Breakdown of academic impact, for papers by J. N. Cohn Breakdown of academic impact, for papers by Jaan Eha Breakdown of academic impact, for papers by Henry A. Oldewurtel
Rankless by CCL
2026